Automatic extraction of retinal vascular biomarkers from color fundus images (CFI) is crucial for large-scale studies of the retinal vasculature. We present VascX, an open-source Python toolbox that extracts biomarkers from CFI artery-vein segmentations. VascX starts from vessel segmentation masks, extracts their skeletons, builds undirected and directed vessel graphs, and resolves vessel segments into longer vessels. A comprehensive set of biomarkers is derived, including vascular density, central retinal equivalents (CREs), and tortuosity. Spatially localized biomarkers may be calculated over grids placed relative to the fovea and optic disc. VascX is released via GitHub and PyPI with comprehensive documentation and examples. Our test-retest reproducibility analysis on repeat imaging of the same eye by different devices shows that most VascX biomarkers have moderate to excellent agreement (ICC > 0.5), with important differences in the level of robustness of different biomarkers. Our analyses of biomarker sensitivity to image perturbations and heuristic parameter values support these differences and further characterize VascX biomarkers. Ultimately, VascX provides an explainabl
Background Identifying the right cut-off for continuous biomarkers in clinical trials is important to identify subgroups of patients who are at greater risk of disease or more likely to benefit from a drug. The literature in this area tends to focus on finding cut-offs for a single biomarker, whereas clinical trials more often focus on multiple biomarkers. Methods Our first objective was to compare three methods,Youden index, point closest to the (0,1) corner on the receiving operator characteristic curve (ER), and concordance probability, to find the optimal cut-offs for two biomarkers, using empirical and non-empirical approaches. Our second and main objective was to use our proposed logic indicator approach to extend the Youden index and evaluate whether a combination of biomarkers is an improvement over a single biomarker. Results The logic indicator approach created a condition in which either both biomarkers were positive or only one of the biomarkers was positive. A prostate cancer study and a simulated phase 2 lung cancer study were used to illustrate approaches to finding optimal cut-offs and comparing combined biomarkers with single biomarkers. Conclusion Our results can
Automated depression detection often relies on static aggregation of conversational signals, potentially obscuring clinically meaningful behavioral dynamics. We investigated whether entropy-driven temporal biomarkers improve depression detection beyond standard pooled features using the DAIC-WOZ corpus. Using 142 labeled participants, we reconstructed utterance-level acoustic trajectories and compared pooled temporal baselines, trajectory dynamics, Shannon entropy biomarkers, recurrence quantification, sample entropy, fractal complexity, and coupling biomarkers under leakage-aware validation. Static pooling achieved an AUC of 0.593, trajectory dynamics improved performance to 0.637, and entropy biomarkers produced the strongest statistically significant improvement over pooled baselines (AUC 0.646; nested cross-validated AUC 0.615; permutation p = 0.017). Entropy biomarkers outperformed recurrence, coupling, sample entropy, and fractalbased features, with several biomarkers stable across folds. These findings suggest depression-related signal may lie less in average acoustic levels than in entropy of conversational dynamics, supporting temporally informed digital phenotypes for men
Cell state discovery is crucial for understanding biological systems and enhancing medical outcomes. A key aspect of this process is identifying distinct biomarkers that define specific cell states. However, difficulties arise from the co-discovery process of cell states and biomarkers: biologists often use dimensionality reduction to visualize cells in a two-dimensional space. Then they usually interpret visually clustered cells as distinct states, from which they seek to identify unique biomarkers. However, this assumption is often invalid due to internal inconsistencies in a cluster, making the process trial-and-error and highly uncertain. Therefore, biologists urgently need effective tools to help uncover the hidden association relationships between different cell populations and their potential biomarkers. To address this problem, we first designed a machine-learning algorithm based on the Mixture-of-Experts (MoE) technique to identify meaningful associations between cell populations and biomarkers. We further developed a visual analytics system, CellScout, in collaboration with biologists, to help them explore and refine these association relationships to advance cell state d
Ratio-based biomarkers (RBBs), such as the proportion of necrotic tissue within a tumor, are widely used in clinical practice to support diagnosis, prognosis, and treatment planning. These biomarkers are typically estimated from segmentation outputs by computing region-wise ratios. Despite the high-stakes nature of clinical decision making, existing methods provide only point estimates, offering no measure of uncertainty. In this work, we propose a unified confidence-aware framework for estimating ratio-based biomarkers. Our uncertainty analysis stems from two observations: (1) the probability ratio estimator inherently admits a statistical confidence interval regarding local randomness (bias and variance); (2) the segmentation network is not perfectly calibrated (calibration error).We perform a systematic analysis of error propagation in the segmentation-to-biomarker pipeline and identify model miscalibration as the dominant source of uncertainty. Extensive experiments show that our method produces statistically sound confidence intervals, with tunable confidence levels, enabling more trustworthy application of segmentation-derived RBBs in clinical workflows.
Despite the diversity and volume of brain data acquired and advanced AI-based algorithms to analyze them, brain features are rarely used in clinics for diagnosis and prognosis. Here we argue that the field continues to rely on cohort comparisons to seek biomarkers, despite the well-established degeneracy of brain features. Using a thought experiment (Brain Swap), we show that more data and more powerful algorithms will not be sufficient to identify biomarkers of brain diseases. We argue that instead of comparing patient versus healthy controls using single data type, we should use multimodal (e.g. brain activity, neurotransmitters, neuromodulators, brain imaging) and longitudinal brain data to guide the grouping before defining multidimensional biomarkers for brain diseases.
This study presents the development and testing of a conversational speech system designed for robots to detect speech biomarkers indicative of cognitive impairments in people living with dementia (PLwD). The system integrates a backend Python WebSocket server and a central core module with a large language model (LLM) fine-tuned for dementia to process user input and generate robotic conversation responses in real-time in less than 1.5 seconds. The frontend user interface, a Progressive Web App (PWA), displays information and biomarker score graphs on a smartphone in real-time to human users (PLwD, caregivers, clinicians). Six speech biomarkers based on the existing literature - Altered Grammar, Pragmatic Impairments, Anomia, Disrupted Turn-Taking, Slurred Pronunciation, and Prosody Changes - were developed for the robot conversation system using two datasets, one that included conversations of PLwD with a human clinician (DementiaBank dataset) and one that included conversations of PLwD with a robot (Indiana dataset). We also created a composite speech biomarker that combined all six individual biomarkers into a single score. The speech system's performance was first evaluated on
Recent years has witnessed an increase in technologies that use speech for the sensing of the health of the talker. This survey paper proposes a general taxonomy of the technologies and a broad overview of current progress and challenges. Vocal biomarkers are often secondary measures that are approximating a signal of another sensor or identifying an underlying mental, cognitive, or physiological state. Their measurement involve disturbances and uncertainties that may be considered as noise sources and the biomarkers are coarsely qualified in terms of the various sources of noise involved in their determination. While in some proposed biomarkers the error levels seem high, there are vocal biomarkers where the errors are expected to be low and thus are more likely to qualify as candidates for adoption in healthcare applications.
Immunotherapy is an effective precision medicine treatment for several cancers. Imaging signatures of the underlying genome (radiogenomics) in glioblastoma patients may serve as preoperative biomarkers of the tumor-host immune apparatus. Validated biomarkers would have the potential to stratify patients during immunotherapy clinical trials, and if trials are beneficial, facilitate personalized neo-adjuvant treatment. The increased use of whole genome sequencing data, and the advances in bioinformatics and machine learning make such developments plausible. We performed a systematic review to determine the extent of development and validation of immune-related radiogenomic biomarkers for glioblastoma. A systematic review was performed following PRISMA guidelines using the PubMed, Medline, and Embase databases. Qualitative analysis was performed by incorporating the QUADAS 2 tool and CLAIM checklist. PROSPERO registered CRD42022340968. Extracted data were insufficiently homogenous to perform a meta-analysis. Results Nine studies, all retrospective, were included. Biomarkers extracted from magnetic resonance imaging volumes of interest included apparent diffusion coefficient values, re
The escalating prevalence of diabetes globally underscores the need for diabetes management. Recent research highlights the growing focus on digital biomarkers in diabetes management, with innovations in computational frameworks and noninvasive monitoring techniques using personalized glucose metrics. However, they predominantly focus on insulin dosing and specific glucose values, or with limited attention given to overall glycemic control. This leaves a gap in expanding the scope of digital biomarkers for overall glycemic control in diabetes management. To address such a research gap, we propose GluMarker -- an end-to-end framework for modeling digital biomarkers using broader factors sources to predict glycemic control. Through the assessment and refinement of various machine learning baselines, GluMarker achieves state-of-the-art on Anderson's dataset in predicting next-day glycemic control. Moreover, our research identifies key digital biomarkers for the next day's glycemic control prediction. These identified biomarkers are instrumental in illuminating the daily factors that influence glycemic management, offering vital insights for diabetes care.
Scope: Biomarkers of food intake (BFIs) are useful tools for objective assessment of food intake and compliance. The aim of this study was to discover and identify urinary BFIs for onion. Methods and results: In a randomized controlled cross-over trial, 6 overweight participants (age 24-62 years) consumed meals with 20 g/d onion powder or no onion for 2 weeks. Untargeted UPLC-qTOF-MS metabolic profiling analysis was performed on urine samples and the profiles were analysed by multilevel-PLSDA, modified PLS, and nearest shrunken centroid to select features associated with onion intake. Eight biomarkers were tentatively identified; six of them originated from S-substituted cysteine derivatives such as isoalliin and propiin, which are considered the most specific for onion intake. Most of the biomarkers were completely excreted within 24 hours and no accumulation was observed during 2 weeks indicating their ability to reflect only recent intake of onions. Receiver-operator curves were made to evaluate the performance of individual biomarkers for predicting onion intake. The area under the curve values for these biomarkers ranged from 0.81 to 1. Conclusion: Promising biomarkers of rece
In clinical trials, identification of prognostic and predictive biomarkers is essential to precision medicine. Prognostic biomarkers can be useful for the prevention of the occurrence of the disease, and predictive biomarkers can be used to identify patients with potential benefit from the treatment. Previous researches were mainly focused on clinical characteristics, and the use of genomic data in such an area is hardly studied. A new method is required to simultaneously select prognostic and predictive biomarkers in high dimensional genomic data where biomarkers are highly correlated. We propose a novel approach called PPLasso (Prognostic Predictive Lasso) integrating prognostic and predictive effects into one statistical model. PPLasso also takes into account the correlations between biomarkers that can alter the biomarker selection accuracy. Our method consists in transforming the design matrix to remove the correlations between the biomarkers before applying the generalized Lasso. In a comprehensive numerical evaluation, we show that PPLasso outperforms the traditional Lasso approach on both prognostic and predictive biomarker identification in various scenarios. Finally, our
With the development of wearable technologies, a new kind of healthcare data has become valuable as medical information. These data provide meaningful information regarding an individual's physiological and psychological states, such as activity level, mood, stress, and cognitive health. These biomarkers are named digital since they are collected from digital devices integrated with various sensors. In this study, we explore digital biomarkers related to stress modality by examining data collected from mobile phones and smartwatches. We utilize machine learning techniques on the Tesserae dataset, precisely Random Forest, to extract stress biomarkers. Using feature selection techniques, we utilize weather, activity, heart rate (HR), stress, sleep, and location (work-home) measurements from wearables to determine the most important stress-related biomarkers. We believe we contribute to interpreting stress biomarkers with a high range of features from different devices. In addition, we classify the $5$ different stress levels with the most important features, and our results show that we can achieve $85\%$ overall class accuracy by adjusting class imbalance and adding extra features r
Accurate and interpretable diagnostic models are crucial in the safety-critical field of medicine. We investigate the interpretability of our proposed biomarker-based lung ultrasound diagnostic pipeline to enhance clinicians' diagnostic capabilities. The objective of this study is to assess whether explanations from a decision tree classifier, utilizing biomarkers, can improve users' ability to identify inaccurate model predictions compared to conventional saliency maps. Our findings demonstrate that decision tree explanations, based on clinically established biomarkers, can assist clinicians in detecting false positives, thus improving the reliability of diagnostic models in medicine.
Joint models for longitudinal biomarkers and time-to-event data are widely used in longitudinal studies. Many joint modeling approaches have been proposed to deal with different types of longitudinal biomarkers and survival outcomes. However, most existing joint modeling methods cannot deal with a large number of longitudinal biomarkers simultaneously, such as the longitudinally collected gene expression profiles. In this article, we propose a new joint modeling method under the Bayesian framework, which is able to deal with longitudinal biomarkers of high dimension. Specifically, we assume that only a few unobserved latent variables are related to the survival outcome and the latent variables are inferred using a factor analysis model, which greatly reduces the dimensionality of the biomarkers and also accounts for the high correlations among the biomarkers. Through extensive simulation studies, we show that our proposed method has improved prediction accuracy over other joint modeling methods. We illustrate the usefulness of our method on a dataset of idiopathic pulmonary fibrosis patients in which we are interested in predicting the patients' time-to-death using their gene expre
Noninvasive brain stimulation and neuroimaging have revolutionized human neuroscience, with a multitude of applications including diagnostic subtyping, treatment optimization, and relapse prediction. It is therefore particularly relevant to identify robust and clinically valuable brain biomarkers linking symptoms to their underlying neural mechanisms. Brain biomarkers must be reproducible (i.e., have internal reliability) across similar experiments within a laboratory and be generalizable (i.e., have external reliability) across experimental setups, laboratories, brain regions, and disease states. However, reliability (internal and external) is not alone sufficient; biomarkers also must have validity. Validity describes closeness to a true measure of the underlying neural signal or disease state. We propose that these two metrics, reliability and validity, should be evaluated and optimized before any biomarker is used to inform treatment decisions. Here, we discuss these metrics with respect to causal brain connectivity biomarkers from coupling transcranial magnetic stimulation (TMS) with electroencephalography (EEG). We discuss controversies around TMS-EEG stemming from the multip
Computational pathology models that use digitized histopathology whole-slide images have the potential to become a cost-effective and scalable alternative to molecular assays for the prediction of genomic biomarkers, a key task in precision oncology. However, as new genomic biomarkers are discovered or quantified, large, labeled datasets must be prospectively collected to train new models. To address this challenge, we developed MARBLE, a multimodal contrastive pretraining strategy that integrates structured biomarker knowledge into representation learning of histopathology images. MARBLE aligns histopathology-derived representations with representations of genomic biomarkers generated by a large language model (LLM) and a protein language model (PLM). This biologically informed alignment enables data-efficient generalization to novel, out-of-distribution biomarkers. Using the MSK-IMPACT cohort of over 40,000 patients across multiple biomarker panel versions, we design experiments grounded in real-world data to demonstrate the value of our proposed approach.
Parkinson's disease (PD) is a progressive neurodegenerative disorder that lacks reliable early-stage biomarkers for diagnosis, prognosis, and therapeutic monitoring. While cerebrospinal fluid (CSF) biomarkers, such as alpha-synuclein seed amplification assays (alphaSyn-SAA), offer diagnostic potential, their clinical utility is limited by invasiveness and incomplete specificity. Plasma biomarkers provide a minimally invasive alternative, but their mechanistic role in PD remains unclear. A major challenge is distinguishing whether plasma biomarkers causally reflect primary neurodegenerative processes or are downstream consequences of disease progression. To address this, we leverage the Parkinson's Progression Markers Initiative (PPMI) Project 9000, containing 2,924 plasma and CSF biomarkers, to systematically infer causal relationships with disease status. However, only a sparse subset of these biomarkers and their interconnections are actually relevant for the disease. Existing causal discovery algorithms, such as Fast Causal Inference (FCI) and its variants, struggle with the high dimensionality of biomarker datasets under sparsity, limiting their scalability. We propose Penalize
Recent advances in experimental methods have enabled researchers to collect data on thousands of analytes simultaneously. This has led to correlational studies that associated molecular measurements with diseases such as Alzheimer's, Liver, and Gastric Cancer. However, the use of thousands of biomarkers selected from the analytes is not practical for real-world medical diagnosis and is likely undesirable due to potentially formed spurious correlations. In this study, we evaluate 4 different methods for biomarker selection and 4 different machine learning (ML) classifiers for identifying correlations, evaluating 16 approaches in all. We found that contemporary methods outperform previously reported logistic regression in cases where 3 and 10 biomarkers are permitted. When specificity is fixed at 0.9, ML approaches produced a sensitivity of 0.240 (3 biomarkers) and 0.520 (10 biomarkers), while standard logistic regression provided a sensitivity of 0.000 (3 biomarkers) and 0.040 (10 biomarkers). We also noted that causal-based methods for biomarker selection proved to be the most performant when fewer biomarkers were permitted, while univariate feature selection was the most performan
Several biomarkers are hypothesized to indicate early stages of Alzheimer's disease, well before the cognitive symptoms manifest. Their precise relations to the disease progression, however, is poorly understood. This lack of understanding limits our ability to diagnose the disease and intervene effectively at early stages. To provide better understanding of the relation between the disease and biomarker progressions, we propose a novel modeling approach to quantify the biomarkers' trajectories as functions of age. Building on monotone regression splines, we introduce two additional shape constraints to incorporate structures informed by the current medical literature. First, we impose the regression curves to satisfy a vanishing derivative condition, reflecting the observation that changes in biomarkers generally plateau at early and late stages of the disease. Second, we enforce the regression curves to have a unique inflection point, which enhances interpretability of the estimated disease progression and facilitates assessment of temporal ordering among the biomarkers. We fit our shape-constrained regression model under Bayesian framework to take advantage of its ability to acc